Cystic fibrosis and the cardiovascular system: the unexpected heartache
- PMID: 37884293
- DOI: 10.1183/13993003.01253-2023
Cystic fibrosis and the cardiovascular system: the unexpected heartache
Conflict of interest statement
Conflict of interest: C.S. Thornton reports grants from Insmed Medical, Trudell Medical and CHEST Foundation, outside the submitted work. H. Hebestreit reports grants from the Bavarian State Ministry of Science and the Arts (BASE-Netz (Network of the Bavarian Working Group on Rare Diseases), Bavarian Genomes), Federal Ministry of Education and Research (Collaboration on Rare Diseases within the German Medical Informatics Initiative), Vertex Pharmaceuticals, and the Innovation fund of the Federal Joint Committee (Dual Guidance Structure for Evaluation of Patients With Unclear Diagnosis in Centers for Rare Diseases (ZSE-DUO)), lecture honoraria from Springer Verlag, Takeda Pharma GmbH and Chiesi GmbH, travel support from European Cystic Fibrosis Society and the University of Edinburgh, and leadership roles with the German Society of Paediatrics, German Working Group of Centres for Rare Diseases and the European Reference Network for Rare Respiratory Diseases (ERN-LUNG), outside the submitted work.
Comment on
-
Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study.Eur Respir J. 2023 Oct 26;62(4):2300174. doi: 10.1183/13993003.00174-2023. Print 2023 Oct. Eur Respir J. 2023. PMID: 37474158 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical